A weak week in the US stock market ended with weakness. My theory that there would be recovery after the Jewish New Year break was too optimistic, and the downtrend resumed. However, the non-US side outperformed the USA today. 

Photo by Adeolu Eletu on Unsplash

Our worst performer today was Japanese Eisai, ESALY, down 4.8%. Other pharma losers included Novacure, NVCR of the Channel Islands, down 3.43%, and Esperion, ESPR, down 3.2%. Cosan is up 1.5%.

The winners included Grupo Bimbo, GRBMF, the Mexican bakery giant, up 12%, It doesn't trade every day. Also up sharply was Energy Fuels, UUUU, up 5.31%, a Canadian firm in nuclear. 

Abcellera, ABCL, a drug firm, rose 2.19%. TEVA of Israel gained 0.6%. Even BiolineRX, BLRX of the USA, is up 1.3%.

Our worst stock pick, South Korean Coupang, rose a half percent. CPNG was floated at an excessive price and fell a lot. It is an Asian version of Mercado Libre which gained 1.4%. MELI is Argentinian but operates all over Latin America.

Chinese car-maker NIO appears to have been able to weather the Beijing crackdown on foreign listed firms better than later entrants and is up 0.93% in a sinking market for Chinese tech. It sold lots of cars last month.

Albemarle ALB, purchased last month, is up 1.4% today. Qualcomm QCOM is up 1.5%. Finnish Sampo Oyj SAXPY is up 0.64%. Asea Brown Boveri ABB is up 0.9%. However, State Street STT, selling 22 mn shares to buy Brown Bros Harriman, is down 0.18%, not as much as I had feared but another drop from yesterday. CBOE is up 1.82% as it builds out its global operations. Sumitomo Mitsui SMFG is up .55%.

Traditional oil producers are back in the black, Royal Dutch Shell B RDS-B by 0.53% and BP plc by 1%.